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Recessive dystrophic epidermolysis bullosa is an in-
herited n'lechano-bullous disorder of skin and U'lU-
cous Inenlbranes. Ultrastructurally, the disease is 
characterized by abnonnalities of anchoring fibrils, 
a ttachlnent structures below the epiderU'lal basClnent 
U'leU'lbrane, cOluposed of type VII collagen. Muta-
tions in the type VII collagen gene (COL7 At) have 
been shown conclusively to underlie dystrophic epi-
derU'lolysis bullosa. Since there is variation of the 
phenotype, accoU'lpanied by heterogeneous anchor-
ing fibril U'lorphology and type VII collagen iU'lmu-
nostaining, it is conceivable that different types and 
combinations of COL7A1 n'lutations correlate with 
different phenotypes. We therefore screened reces-
sive dystrophic epidennolysis bullosa patients for 
COL7Atmutations. Three unrelated patients showed 
the same prcluature tennination codon luutation in 
exon 13 of one allele, yet they were all cOinpound 
heterozygotes, each having a different mutation in 
D ystrophi c epide rm olys is bull osa (EB) is an inh e"it:ed mechano-bullo us discasc ch aracte ri zed by bliste r-ing and sca rrin g of th e sk in and mu cous m em-branes. Various sub types arc d escribed on thc ba sis of patterll of inh e ritance. les io n distributio n . and 
severity of di sease (Fin e 1'1 ai, 199 1). Ultrastru c tura l studies have 
shown abnormalities of an cho ring fibril s, a tta chment stru ctures 
ben eath the lamin a densa o f the epide rmal basement m embrane . in 
a ll forms of dystrophic EB (T idlllan and Eady. 1985). Furtherm o re, 
immunosta inin g with antibodies to type V II colbgcn. the major 
component of anchoring fib ril s, sh ows redu ced or absent sraining in 
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the second allele . The first patient had a premature 
tern'lination codon within the collagenous region of 
COL7At associated with severe disease, absent an-
choring fibrils and undetectable type VII collagen 
irnmunostaining. The second had a prenlature termi-
nation codon in the non-collagenous NC-2 region 
associated with severe disease, wispy anchoring 
fibrils, and patchy type VII collagen imInunostain-
ing. The third had a glycine-to-aspartic acid substi-
tution within the collagenous region, associated with 
Inilder disease, no identifiable anchoring fibrils , but 
near normal type VII collagen iU'lmunostaining. We 
conclude that the nature and position of Inutations 
within COL7 At correlate with specific disease fea-
tures and n'lay provide an insight into the U'lolecular 
U'lechanisms of anchoring fibril formation and epi-
dcrU'lal-dern'lal adhesion. K ey lVonts: skill diseaseslve-
siCl/lobllllollsltJ'pe VII collagell{lIitmstl'llctlll'e. ] Illvest D el'-
lIIato/ 107:171-177, 1996 
most cases (Heagerty el al. 1986; Bru ckn er-T Llderman CI al. 1988). 
R.ecess ivc dystrophi c EB is linked to COL7A l at 3p21. and there is 
no ev idence of locu s h eterogeneity in any of the dystrophic EB 
hllllili es studied thus ta r (Hovnanian ('I al. '1 992 : Dunllill CI ai, 1994a: 
U itto and C hristiano . '1994). 
Seve",,1 COL7 A l mutati o ns have now been described, co n fi rm-
in g the pathogen ic ro le of this gen e in dystrophic EB . Various 
premature te rmination codo ll (PTC) mutations have been sh own to 
underlie severe gen erali zed recessive d ystrophic EB (Hilal et ai, 
1993 ; C hristiano et al. 1994 a, 1995a ; Dunnill el al. 1994b; Hovn3-
nian ('1 al. 1994) . These mutations lie w ithin the amin o- te rminal, 
non-collagenous (NC-l) domain or n ea r the amin o-termin al end of 
the collagenous he lix . Tn a famil y w ith recessive dystrophic EB 
mitis. a h om ozygous m ethionine-to-lysine missen se mutation 
within the carboxy-te rmin al. n o n-colla gen o us N C - 2 domain has 
been described (C hristiano ct ai, 1993). Las tly. three dominant 
dystrophic EI3 famili es h ave been idenrjfted , each with glycin e 
substi tutions within the co ll agenou s domains (C hristiano rt ai, 
1994b , 1995b , 1995c). T hu s. these o bser va ti on s suggest a corre la-
tion between COL7 A 1 mutations and resulting ph enotype of 
dystrophic EB . Much of the variatio n, however. in clinical pheno-
type. iml11un ohistoch emistry. and ulrrastru cture within th e various 
0022-202X / ')(,/S I O.SIl • Copyright (['l 1996 by T he Society for Investigative Dermatology. Inc. 
171 
172 DUNN ILL ET AL T HE JOU RNAL OF INVESTIGATIV E DERM ATOLOGY 
Table I. Clinical Fea t ures o f the Patients 
Pati ent 
2 3 
Age <It prCSCll t~l tio l1 13 irth Bi rth 
Age at ti lll e of stu dy (yea rs) 




Gen erali zed 
Birth 
27 
Localized , w ith acral and sol11e flexural involvement 
M ode rate pseudosyndactyly I-land deform ity 
Esophagea l strictures 
Severe. l11i ttc n ha nds 
Moderate 
Severe , Illi ttcn hands 
Severe M oderate 
Dell ta l changes 
Constipation 
Squamo us cel l c .... cino l11 " 









su btyp es still awaits molecula r expl an a.tio n . For example, in reces-
s ive dystrophic EB, m a n y indi vid uals h ave in verse o r o th e r over-
lap p in g ph e n o typ es (B ruc kn er-T ude rman rl (I I , 1990; Ead y, 1990). 
S u c h clinical h eterogen e ity is mirrored b y ul tr as tructural and 
i m muno histoch e mi cal v;ll·iatio n (E ru c kn er-T udem1;\11 ef ai , 1988; 
McGrath eI ai , 1993). Some studi es u sin g a n tibo dies direc te d again st 
t h e NC-·I d omain sh ow n o type VIl colla gen express io n in 
gen e ral ized recess ive dys trophic EB (Le ig h el ti l, 1988) . O the r 
work ers h ave fo u nd ty p e VII colbgen express io n to b e r e duced but 
p rescn t in s li c h patic n ts ( Ru se nko el ai, 1989; M cG rath cI ai , 1993 ). 
tn con trast, in in ve rse dystrophic EE , br-ig ht imm lln os tainin g occurs 
w ith o u t recognisable <l n Ch o l;ng fibri ls on e lectro n mi c roscop y 
(Bru ckn er-Tuderm an c/ il l , 1990; Fin e ef aI, 1990) . O n e p ossible 
exp lanation tor t h ese fi n d in gs is t h at th e n atllrC o r locatio n of 
COL7A 1 m utations d etermin es diffe re n t c1ini c;'Ii , ultrastru ctura l, 
and imm un o h istoch e mical features . 
In chi s stu d y we d escribe three unre late d p ati e n ts w h o are 
co m poll n d h eterozygotes fo r COL7 A I. rnut,ltio n s. Sin ce all three 
h ave o n e m u tation in commOll b ut h ave a diffe r e n t second mu ta-
tion , d irec t compa ri son b etween th e ph e n o types, presumabl y r e -
Aecting th e nature of th e seco nd alle lic mu ta ti o n , j .~ poss ib le . 
MATER IALS AND M ETH ODS 
Patients and Sam p l es T h" thrce patients had a standard clini cal history 
an d exarnin .. \t\on to dO Cl1 n1cn t th e dc.grc.c of cu taneous in vo lvcl1u!ut and 
othe r conl plicatio ns. slI c h as con t ractun::s , esophagea l stri cture o r an clTli a. 
After in fo rmed patient co nsent, a skin biopsy was o h t,Jined fi·om I.Inblis-
tered, u nse,,.-red skin after ~entie rubbing, from uppe r inne r arnl o r thi~h . 
Contro l sk.in sa /ll p les were o bta ined fro m bre:lst red uctio n .surge ry. Ethi c;1l 
Committee " pprova l was o bw in ed for the stu dy. 
Indirect Immunofluo r escen ce Five m icrometer cryostat sectio ns we re 
incub" tcd with p rimary antibody, washed in p hospha t" bufl"e rcd sa line , <lnd 
incub;,tcd wi th f1u oresccin-co,vugatcd second" ry an tibo dy as pre vio usly 
described (Kennedy cl ai, 1985) . LH 7:2 m OLl se mo noclonal antibo dy 
(p rovided by Prof. I.M . Leigh , Iloyal Lo ncion H ospita l, Lo ndo n , U .K.) was 
used as t he primary antibody (Lei~h /'I (/f, 1987) . T hi s is directed aga inst an 
epi tope in the NC-1 re~ion of the type VII co ll age n 111 0 lecule (Tanaka c / ,,/, 
1994). Myelom a se ru m was used as a negative control. Sections were 
view"d and photOgraphed using a N iko n O ptiph ot 2 m icroscope equ ipped 
fo r ep iRuorcsce nce . 
E lectro n Micr osco py S.n:1I1 sa mples of sk.in «2 nlln ' ) we re proces.sed 
fo r electro n microscopy using standard me thods (En dy, 19H5) . Samples 
were suhjected to prim" ry fixatio n. in hal f-stre n ~th Ka rno vsky fixative 
innlled i"tcly after bi op.sy. Ali:er secouda ry fixa tion ill 1.3'X. osmium tetrox-
ide, the sarnpl cs were de h ydrated in e [hano l, stained e n bloc using 51% 
uran yl acetate in 50%, alcoho l, and e mbedded in Epon resin (TAAB 
Ia bonlto ri es , Alde rl11 ilSton. Berks , U.K.). U ltrathin sectio ns. sra i.ll:d w ith 
Reyno ld 's lead citrate, Wl!re observed under a J EO L 100CX transmiss io n 
electron rnicroscopc. 
Immun oelectron Mi croscopy Sm ail pi eel!' o f sk.in «2 mll.-' ) were 
subj l!cted to pre-em bedding im ll1ullo labe ling wi th LH 7:2 primary an tibody 
and l nm gold-co nju gated secondary an tibody as prev io usly desc ribed 
(McGrath 1'1 of, \ 993). Mydom a serum waS used as a nq;"tivl! comro l. 
Prim ary tixatio n was pcrfo rn wd w ith half- strength Karnovsky fi x:ltive, 
fo llowed by en bloc si lver elll];lllce ,."e", and seconda ry I1x;ltio ll. Ultrathin 
sections were taken from the edge of the ti ssue block. . 
Mod erate 
M o derate 
N Olle 
Mild 
Mu ta tion An a lysis Genomic DNA iso lated !Tom peripheral blo od lym-
phocytes w aS used as the template for po lym erase chain reaction (PC R ) 
amplif,c<.tion o f 140- to 400 - bp fr agm en ts spanning all 118 exons of 
COL7 A 1. Exon 13 was am pli fi ed using prime rs and conditio ns as described 
prev io usly (D unn ill el 01, ·1 994b) . Exo ns 103 and 104 we re ampli fi ed using 
the sellSl! prime r 5 'CGGGCT CGTTGTATTCTAA3 , ,wd the anti sense 
primer 5 'TCAAA AGCTACC ACACT GGT3 ' , w ith denaturatio n at 95°C 
fo r 5 min , followed by 40 cycles o f 95°C fo r 1 min , 55°C fo r 1 min , and 
72 °C for 1 min . Exom 74 and 75 were ampli fi ed using the sense primer 
S'CCAGGAG AGTG AGGGAAG AG3' and the antiscnse primer S'TAG-
GGTCAG AAATT CC AGGG3' with denaturation at 95 °C fo r 5 min fol-
lowed by 40 cycles o f 95 °C fo r 1 min, 60°C fo r 1 min , and 72°C fo r 1 min. 
Exons 114 and 11 5 were amplified using the sense primer 5'GT CTCT C-
TA TCCCTCTCTGCCCCC3' and the ami sense prime r 5' A GCTGC-
CCCACGGGT TCAGCTGTC3' with d enatu ration at 95 °C fo r 5 mlll 
fo ll owed by 30 cycles of 95°C for ·1 mill , (,5°C for 1 min, and 72°C for 1 
mill . PCR pro duct.1 were prl!pafed fo r sing le- str:lnd conformatio n po lymor-
phism an;" y, is as pre viously described (Dockhom-Owoniczak el 01, 1991), 
o r 11 ctcroduplcx an alysis according to 111 anu fi,cturer 's rccorn lnend<ltions 
(MO E, JT 13" ker In c., Phil lipsburg, NJ) . DN A samples from a panel of 
d ystro phic Ell patients and contro ls we re run silTlul taneo usly. Samples in 
which band shifts were detected fo r a particul ar exon were subclon cd into 
TA vector (Invitrogen, San Diego, C Al and Sanger sequel1 cl!d w ith the 
Seq ucnase kit (USB , C leveland , 0 1-/) . Alte rnativel y, PC R products display-
ing b ;lIlds of altered m obili ty we re seque nced directly using the Alli 
autom ated sequencing system . In patient 2, lTI essenge r R.N A w as pre pared 
l1·o lT1 a bloc k o f skin fj·ozcn in liquid nitrogen using U ltraspec (Biotec:<, 
Hou sto n , TX). First- strand eDN A synthesis andPC R. was perfo rmed using 
First-Strand syn thes is ki t (Pharmaeia Biotech , St . Albans, H erts, U.K.), and 
the sellSe prime r 5'GAGAAGGGAGA AGCT GCACT GACG3', and the 
anti sense prime r 5 ' CTGTCCCCTGGCT CT GG ACCACCC3' under the 
fo llow il1 ~ cond itio ns: 95°C for 5 min , t he n 3S cycles of 95°C fo r 1 min. 
55°C fo r 1 m in, and 72 °C fo r 1 min. Nes ted primers w ere used in a further 
ro und of PC R. using fo rward primer S' GCTTfGT GCGCCAAG AGAT-
GAGTC3', reVCrse prime r 5'T CACTATCCCAAGGAGCTTC AGGG3 ' 
under thc fo llowing conditions: 95 °C fo r 5 min, the n 40 cycles o f9 S"C for 
1 min , 55°C fo r 1 l11in, and 72°C fo r 1 m in . 
V e rifi c ation of Mutations W e sou~ht restri cti o n en zym es whose reC-
ognition site was altered by the mu tation s det<:etcd. Where possible, ti11! 
mu tati o ns we re verifi ed lI sing gC I1 o l11i c DNA fro III patien ts cllld o ther f.1 mily 
nWlIlbcrs. PC lt of the appro pria te fi·agm cnt and restri cti o n " nzyl11 e diges-
tio n w as perfo nll l!d. 1n patie nt 2 , the dele ti o n cou ld be detected using 
electropho resis of PC R products o n a 12'!/" polyacrylamide gel. N o rmal 
contro ls were aho analyzed fo r the .sam e mutan t sequences. 
RESULT S 
Clinical F e a tures All three patients had typica l f:'l mi ly histories 
of a u tosom a l recess ive d ystrophi c EE. Th e ll1<uor clinical fea tures 
a r e lis te d in Table I . 
Irn mul1ofluorescCl1CC Microscopy Indirect irnmunoAuore-
cen ce w ith t h e LH 7:2 antibo d y sho w e d brig ht lin c ar staining a long 
th e d e rm al- e pide rmal junc tio n in un affe cted skin from th e c ontrol 
(F ig 10) . In skin se c tio n s fro111 p<ltie nt 1 , staining was absen t (Fig 
Ib). Secti o n s fro m pa t ie nt 2 showed fa int, p a tc hy stainiJl g a lon g the 
d e rma l- e pide rmal junctio n (Fig 1c) , and in sk in from patie nt 3, 
mu c h b r ighter lin e,lr st a ining wa s o bse rve d of simila r inte n sity to 
the control (Fig 1d) . 
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Figure 1. Variation in staining with anti-type VII collagen anti-
bodies. Indirect inlll1UIlOflu o rcsccl1 cC \·vns perf o 1"111 cd using the LH7:2 
antibody on skill from cOll trol (n) . paticlH I (b) . patient 2 (f), and patient 3 
(d) . Senfe lln r.<. 50 [.L1f) . 
Electron Micr o scopy and Immunoelectron Microscopy In 
all cases, th e level of d ermal- epidermal separatio n was be neath the 
lam in a densa (da ta not sh o wn). Immunoelectr'on microscopy in 
contro l skin sh o w e d numero us an cho ring fibril s lab eled with 
immunogold-silver LH7: 2 antibody (Fig 2a). lmmllnoelectron 
microscopy in pa tient 1 showed a lack of discerni b le an cho ring 
fibrils as d e fin ed b y T idman and Eady (1 984) and fa il ed to 
dem o nstrate an y specifi c labe lin g of the lamin a de llsa o r subl al11ina 
d ensa structures (Fig 2b) . [n pa tient 2 , no n o rmal anchorin g fi brils 
were discernible , but a fe w wispy stru ctures, som e of which sh o w ed 
specifi c il11munogo ld-sil ve r labe ling usin g LH 7:2 , wer'e visibl e 
below the lamina densa (Fig 2c) . Patien t 3 a lso sho w ed no 
identifi able an ch o ring fibril s, but here the lan"tin a densa showed 
defmite immuno labeling wi th LH7 :2 (Fig 2tf) . 
Identification of COL7A 1 Mutations 
A ll Palic/ll s A re Hetcrozygo lls fo r R 578X W e previously described 
trus C -to-T transi tion a t positio n 1732 (numbe rin g as in E MBL 
GenBank no. L02870) chan ging a codo n fo r arginine in exon 13 
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Figure 2. Va,riation in anchoring fibril stru cture. 1111l11ut1oelecrron 
microscopy was pe"fo rmed using the LH7:2 anti body. Control skin shows 
numerous an choring fibril s below the lamina densa that label with gold-
silvcr LH7:2 antibody (flIl'a ,,,s) (a). Skin from patient 1 shows lack of 
recognisablc anchoring fi bril s and no specitic labeling of lamina densa or 
Sllblamina densa structures (II) . Skin from patient 2 shows the presence of 
wispy fi brillar stru crures below the lamina densa. some of which label 
specifica ll y with immllnogold-silver (nmlll's) (c). Ski n from patient 3 shows 
abundant labeling of the lamin a densa and occasional labeling within the 
dermis. No identifiable fi brillar structures. howevcr. arc observed below the 
lamina densa in association with immllnogold-si lver labcl (d). Senf" bflle<. 0.5 
[.LJ11 , 
in to a stop cod on in two cousins fro m Ital y (DunnilJ cl ai, 1994b). 
T his mu tatio n, des igna te d as R 578X, ab o lish es a restriction en zym e 
site fo r X lto[ and screening exon 13 w ith X IIIJ I digests su ggested th at 
these three unrelated B riti sh patien ts w ere h eterozygotes fo r this 
muta tio n. Sequ en cing of gen o mic D N A con fi rmed th e mutation 
(Fig 3) . 
All Palicllls A rc CO II/polllld HClcrozygotcs f or a DijjerCII I COL7A1 
M II/alioll ill rl, c Sccolld A I/e1e In pati en t 1, an alysis of exons 103-1 04 
showed a h e te ro dllplex band. Seque n cing of this fragm en t revealed 
a de le ti on o f G a t position 7786 ca using a fram eshi ft w hi ch led to a 
PTC in exon 106 (F igs 4a, b). T h e mu tatio n was con fi rmed using 
Bsafl digests of gen o mi c D N A, and segregatio n w ithin the fa mily 
was de m on strated (Fig 4c). 
In patien t 2 , heterodupl ex es were o bserved on analysis of exons 
11 4 -11 5 . An additio n al fas te r migrating band was also o bserved , 
su ggestin g a deletio n w ithin this fragm ent (Fig 5a) . Sequen cing of 
gen o mic D N A revea led the d ele tion 844 '1-1 4de I21. w hich in-
cluded the spli ce accep tor si te at the in tron 11 4/exon 115 bo rder 
(Fig 5/1). Examin ation o f reverse transcription - PCR p roducts of 
exons 113-11 6 o n 12'X, po lyacrylamide gel e lec tropho res is reveal ed 
an extra fas te r m igratin g b and (Fig 5tf) . Sequ en cing of cDN A 
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Figure~, All patients are heterozygous for RS78X. Sequence of exon 
13 in patient 2 and in control is shown, The same sequence was obta ined in 
patients 1 and 3, 
obtained from dOlles and from excising the mutnnt band from tbe 
12% polyacrylamide gel sh owed that this deletion resulted in 
aberrant splicin g, de leting 13 bp fi'om the open read in g frame and 
creating a PTC in exon 117 (Figs Sc,e). Segregation within th e 
fa mily was demonstrated by detection of the de letio n ITom geno mi c 
DNA on heteroduplex analysis (Fig 5C1). 
fn patient 3, ana lys is of ex om 74 -75 revea led " hetemd uplex 
band, and seq uencing demonstrated a G-to-A transitio n at position 
6218, ch anging a codon for glycine (GeC) in to aspartic ac id 
(GAC), which creates an MlIlo \ restrictio n enzyme site (Figs 6a ,b) . 
Analysis of the other fa mily members, however, showed no 
evidence of the mu tation in genomic DNA in eithel' parent (Fig 6c), 
T he first m u tation, R 578X, occurred in the mother, suggesting 
e ither that geml line m osaicism for this mu tation was present ill the 
fath er or that this was a new mutation. We were unable to test 
sperm to confi rm thi s. Paternity testing using the mu ltilocus probes 
33.15 and 33.6 (Cell m ark Diagnostics, Abingdon , U.K.) excluded 
non-paternity (data not shown) . 
No evidence fo r the presence of any of these mutations was 
found in a panel of 36 alleles from 1. 8 normal indi vidual s usin g 
restriction enzyme or e lectrophoretic analyses. An additiona l 32 
norma l individuals and 38 dystrophic EB patients were screened for 
the presence of the G- to-A transitio n at nucl eotid e positio n 62] 8, 
and no evidence for this mutation was found . 
DlSCUSSION 
We have described three recessive d ystrophic EB patients who are 
compound heterozygotes for COL7 A 1 mutations, T hree of these 
mutations are novel, and o ur data ex tend the ev iden ce for the 
causative role of COL7 Al mutations in this disease. Because all 
three patients possess one common mutation, R578X, direct 
comparison of the effect of the differen t second mutations is 
possible . RS7BX is like ly to produce unstable mRNA and severely 
red uced amounts of transcript (Baserga and Benz, 1988). Alterna-
tively, the exon bearing the PTC might be skipped as demon strated 
in the fibrillin 1 gene in the Marfan syndrome (Dietz et at, 1993), 
although no evidence for th is m echanism has been found in 
COL7Al (Hilal et aI, 1993). T hus, the most like ly consequence of 
R578X in our patients is a functiona l "knockout" of this allele. 
In patient 1, the second mutation resu lted in a PTC in exon 106, 
nea r the carboxy-terminal end of the collagenous region. Again , 
this would b e likely to result in reduced amounts of transcr-ipt, and 
we predict that this mutation would serio usly impa ir the formation 
and subsequent secretion of hom otrimeric type VII collagen m ol-
ecu les. Our data support this hypothesis as immunostainin g w ith 
LH7:2 , which labe ls an e pi tope w ithin the NC-l domain (Tanaka 
et nt, 1994), showed 110 sta ining of the dermal- epidermal junction. 
Furthermore, 110 anchoring fibrils were observed by electron or 
immunoelectron microscopy. 
THE JOURNAL OF IN VESTIGATIVE DEIl.MATOLOGY 
T he second mutation in patien t 2 was a 21-bp dele tion, w hich 
caused missplicing and also produced a PTC in cxon 11 7, within 
the N C- 2 domain. W hereas reduced mRNA levels have b een 
demonstrated as a result of PTCs at the amino-terminal and centl'al 
region of val; ous genes, a PTC at the carboxy term inus is less 
damaging and can be associated with I1 0rmal transcript levels (Peltz 
ct ai, 1993) . Unfortunate ly, mRNA to test the transcrip t levels was 
unavai lable. N evertheless, transcript from this allele is predicted to 
m isread 84 amino acids and encode a polypeptide lackin g the last 46 
residues of the NC-2 domain . Immunofluorescence using LH7:2 in 
this patient's skin shows scanty type VIl collagen exprcssion along 
the dermal- epidermal junctio n . In addition, w ispy structures that 
label w ith L1-I7:2 antibody sugges ted tha t som e rudimentary an-
cho ring fibriJ s are being formed. This l11u tl,tion could interfere wir.h 
type VII coHagen assembly into ,mch oring fibrils by two m echa-
nism s. First, formation of the triple helix fi'om a 1 (V ll ) propeptide 
may be impaired (Burgeson et ai, 1990). Second, cleavage of the 
N C - 2 domain dudng formation of antiparallel dime rs m ay not 
occur as the putative cleavage sl te is w ithin exol1 115 (Bruckner-
T uderman t:I aI, 1995) . Our data g ive suppo rt to the hypothesis that 
the NC-2 regio n is cri tica l for fibril formation. 
Patient 3 has a glycine-to-aspartic acid substitution in exon 75 on 
the second mutant allele. Glycine substitutions are a well-recog-
nized ca use of tl;ple he lix instabili ty in coll agen m o lecules 
(Prockop, 1992). H e terozygo us glycinc substitu tions in type VII 
collagen have been shown to resu lt in dominant dystrophic EB in 
three unrelated pedigrees (ChristimlO ct nl, '1994b, 1995 b, 1995c). 
In o ur patient, beca use th ere is a nOll-sense mutation on the other 
allele, the only type V ll coll agen protein available for h omotriJ11er 
del G 
a Intron 105 I exon 104 + 
sense 3' AA TGGCCCAGTGNCCCCAAGG 5' 
b II,lron 105 I exon 104 








Figure ~. Patient 1 is heterozygous for 7786delG. Automated se-
quence of intron 10S!cxon 104 in patient 1 (a) and control (b), There is a 
heterozygous deletion ofG caus ing a framcshjft, The seq uence to the 5' side 
of this mut:ltion is ambiguous because of the frameshift. BsaJ l digests of 
PCR products of ex OIlS 103- 104 from the family of patient 1 were run 01\ 
a 2')\, agaros" gel (c). T he Illutation abolishes the restriction enzyme site alld 
leads to an extra band of 186 bp. Eleven other cleavage sites arc normally 
present within the S04-bp PC R. product, giving fragments of '132 bp. 120 
bp, and several of less than 100 bp . 
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fo rmation is also ab no rmal , carryiJlg the g lyc in e-to-aspartic acid 
m u tation. T he resulting ph enotype is onl y l11 0 de rate ly severe with 
som e features of in verse dystro phic El3 . T he paradoxical fi ndin g of 
brigh t iml11unosta ining w ith anti-type V II collagen an tibo dies and 
lack of an ch oring fibri ls in the in verse fo rms of recessiv e d ystrop hic 
EB has pre vi o usly been reported (Druckner-T udennan c ( ai, 1990; 
Fin e el ai, 1990). Although thi s patient does n ot have a ll the features 
of an inv e rse phen otype, the m olecular find in gs m ay go some way 
to exp lain in g this paradox. B ri ght linear illlrtl Ull Oliu o rescen ce using 
LH7: 2 m on oclonal antibod y indi ca tes tha t expression of the epitope 
in the N C -l regio n o f type VII co ll agen is allowed by th e glycin e 
mutation. Lack o f recogn izable ancho rin g fibri ls o n e lectro n mi-
croscopy , howe ver , implies that anchorin g fibril assembly is co m-
promised. presumab ly b y impaired latera l aggregation of dime rs 
caused b y the e fFec t of th e glyc in e substitutio n upon the qu ali ty of 
th e he lix. 
In thi s study we ha ve dem o nstra ted the presen ce of R 57SX ill 
three unre lated Briti sh indi v idu als, and we h ave previo usly iden ti -
fied this l11utation in ano the r pa tient £i'o m I ta ly (D unni ll 1'1 al. 
1994b). Hap lotype ana lysis llsin g the PIIIIII R.FLP marker (D un nill 
el ai, 1994a) (data not show n) demo nstra ted that R 578X segregates 
w ith both P/llIll a llel es, suggestin g t hat the mu tation has arisen 
CCCTAGTT ATG 5' 
C.'\~lr l 115 
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Figure 5. Patient 2 is h e terozygous 
for a deletion of the splic e acceptor 
site at the il1trol1 114/exol1 115 bor-
der. Hctcroduplex analysis ofPCR prod-
ll cts of gCllo J11i c DNA spannin g CXO IlS 
11 4-11 5 was performed on the fa illily of 
patienr 2 (a). H , HOl11oduplex ; iI. hetero-
duplex. In addi tion to the expected ho-
mod uplcx band of 3 17 bp there is a faste r 
migra ting band of 296 bp. suggesting a 
de letion. Genomic DNA in patient 2 and 
control was sequcnced across the intron 
1 141 cxon 1.1 5 border (I,). eDNA in pa-
t ient 2 and contro l \vas sequenced a c rOSS 
thc cxon . 114/ cxon 11 5 border (f). 
T,vc)ve percent polyacry latnidc gel elec-
trophores is of R T - PCR products of ex-
ons 11 3-116 was perfon11ed all patient 2 
(P). and control (C) (if) . A schematic 
diagram shows the result of this sp lice 
acceptor site deletion . Shaded box repre-
sents the de letion fi'o lll genomic DNA. 
T he CCCCT l1Iotif, arc in IJoI1fa(c. A 
cryptjc AG splice acceptor si te. 13 bp into 
exon '11 5 is activatcd (e). 
independently at least tw ice. T his is not surpnsm g as the CpG 
d inucleotide is susceptab le to C-to-T transition by virru e of che m-
ica l in sta bility (Youssou fia n e( ai, 1986) . T he de letion of the intron 
11 4/ exon 115 spli ce acceptor site is a novel m ech ani sm in dystro-
p hic ED . A CCCT m otif occurs within intl'on 11 4 and again w ithin 
exon 11 5, separated by 16 bp. The m echani sm of the deletion is 
li ke ly to be aberra n t nucl eotide misspai ring during DNA repl.ica-
rion , with resultan t deletion of the 21- bp fragm ent. R ath er than 
resu ltin g in skipping of exon 115, o ur resul ts sh ow that a cryptic 
splice site within exon 11 5 is activated. T his fram eshift mutation 
leads to mistran slation of exons 115 and 116 and a PTC in exon 
1 17. 
T he g lyc in e substitution dem o n strated in patient 3 appears to be 
a new mutatio n . T his mutatio n might have a do minan t negative 
efFect' if paired w ith a no rma l COL7 A 1 aUele. T his afFec ts gen etic 
counse li ng, beca use the usua l advice for thi s au tosom al recessive 
disease is that, p rovided the re is n o con sanguini ty, the ri sk of the 
p ro band h avin g an a fFected child is very sma ll. In patient 3, our 
filldill gs sugges t that he r children have a 50%, ch ance of inheriting 
the glycine substitutio n mutation . T his cou ld lead to the dominant 
dyst ro p hic E B phenotype. A ho m ozygous g lycine substituti on in 
the typ e V II co llagen he lica l do main has been dem o n strated, 
176 DUNN ILL c r , 11_ 
a G lo A 
,n lr on 7. 1+ exon 75 
5 ' e N TGC AG G N CAG AG A TGGN C C TC 3' 
b In\ron 7 t1 I axon 75 




Figure 6. Patient 3 is heterozygous [or a glycine to aspartic acid 
substitution in exolt 74. EX-Oil 74 W;IS sequenced Llsing atlto ill atcd 
sequence r in pati e nt 3 (n) a n d control (b) . Mil'o I restrictio n e n zylll e diges ts 
were used to screen gen o mi c DNA PC R produc ts of ex O IlS 74-75 in th e 
r,' lIlil y of patie/H 3 (c). T h ese we re run o n :I (, 'Y" pol yaco-ylalllide g e l. The 
370-bp PC R produc t is n o nnall ), cl e aved illto fi'agmcnts o f 'l 67, 166. :lnd 
37 bp, vis ibl e as a sin g le h and. T h e lIlutatio n aho li sh es o n e restric t io n 
CIl ZYlll C site resulting ill an ex tra 204 - bp balld . 
howe ver, in association with recess ive rather than dominant d isease 
in o ne fami ly (M cGrath e/ nl, 1(96). T hlls, genotype anal ys is in 
recessive dys trophi c EB patients ma y enable m o re aCClll'ate geneti c 
co unselin g. 
Finall y, although it is not possibl e to draw f-irm conciu siollS on 
the corre lation of clini cal phe notype with the un derlyin g mutatio n 
fi'om thi s study of three patients, as further Illutations arc described 
alo ng with the res ulting p henotypes , a clearer understandin g o f 
precise genotype/phe notypc correlations sho uld cmerge. T his will 
enabl e hi ghly accurate p rognoses to be givc n in int~lIl ts presen tin g 
with recessive dystrophi c EB. 
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